Integral Diagnostics Limited (ASX:IDX) Insider Ian Kadish Acquires 25,000 Shares

Integral Diagnostics Limited (ASX:IDXGet Free Report) insider Ian Kadish bought 25,000 shares of the stock in a transaction dated Wednesday, March 5th. The shares were purchased at an average cost of A$2.16 ($1.37) per share, for a total transaction of A$53,950.00 ($34,145.57).

Integral Diagnostics Price Performance

The firm has a market capitalization of $1.10 billion, a price-to-earnings ratio of -11.45, a PEG ratio of 1.39 and a beta of 0.73. The company has a quick ratio of 1.84, a current ratio of 0.86 and a debt-to-equity ratio of 118.59.

Integral Diagnostics Dividend Announcement

The firm also recently announced a Interim dividend, which will be paid on Sunday, April 6th. Stockholders of record on Sunday, April 6th will be paid a dividend of $0.025 per share. This represents a dividend yield of 1.06%. The ex-dividend date is Wednesday, March 5th. Integral Diagnostics’s payout ratio is -23.08%.

Integral Diagnostics Company Profile

(Get Free Report)

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.

Read More

Receive News & Ratings for Integral Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.